Related Experiment Video
Updated: Jun 3, 2026

Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Central nervous system toxicity associated with liposomal amphotericin B therapy for cutaneous leishmaniasis
Jessie S Glasser1, Clinton K Murray
1US Infectious Disease Service, Brooke Army Medical Center, 3851 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA. Jessie.glasser@amedd.army.mil
Abstract:
AmBisome (liposomal amphotericin B) is used for prophylaxis and treatment of fungal infections, treatment of visceral leishmaniasis, and more recently, treatment of cutaneous leishmaniasis. Although the package insert cites neurologic toxicities in up to 20% of cases, review of the literature did not reveal any specific cases describing this side effect, particularly in a patient without comorbidities. We describe a healthy 38-year-old male treated with liposomal amphotericin B for cutaneous leishmaniasis acquired during military duties in Iraq. Shortly after completion of his treatment course, he reported memory difficulties and confusion. Further evaluation revealed no other source, and his cognitive issues were attributed to liposomal amphotericin B toxicity. These issues resolved over a few weeks, which is consistent with data about the drug's tissue penetration and metabolism available in the literature. This is a potential side effect of liposomal amphotericin B that can be observed in otherwise healthy patients.
Insights
Liposomal amphotericin B, used for fungal and leishmaniasis infections, can cause temporary cognitive issues like memory loss and confusion. This side effect may occur even in healthy individuals without other health problems.
Area of Science:
- Pharmacology
- Infectious Diseases
- Neurology
Background:
- Liposomal amphotericin B (AmBisome) is a key antifungal and antileishmanial agent.
- Neurologic toxicities are listed as potential side effects, but specific case reports are rare, especially in healthy patients.
- Cutaneous leishmaniasis is treated with AmBisome, particularly in endemic regions or for military personnel deployed in such areas.
Observation:
- A healthy 38-year-old male developed memory difficulties and confusion after completing a course of liposomal amphotericin B for cutaneous leishmaniasis.
- No other cause for the cognitive symptoms was identified.
- The patient's symptoms resolved spontaneously within weeks.
Findings:
- This case suggests that liposomal amphotericin B can cause reversible cognitive side effects, such as memory impairment and confusion.
- The observed toxicity occurred in a patient without comorbidities, highlighting a potential risk even in healthy populations.
- The resolution timeline aligns with the known pharmacokinetic profile of liposomal amphotericin B.
Implications:
- Clinicians should be aware of the potential for cognitive side effects with liposomal amphotericin B, even in immunocompetent patients.
- Early recognition and monitoring of neurologic symptoms are important during and after treatment.
- Further research may be warranted to fully characterize the incidence and risk factors for AmBisome-associated neurotoxicity.
Related Concept Videos
Antifungal Agents
Antiprotozoal Agents
Leishmaniasis
Cryptococcal Meningitis
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...

